OBJECTIVES: Primary @entity1119 usually affects the hands, armpits, feet and cranio-facial region. Sweating in other areas is common in secondary @entity1119 (after surgery or in specific clinical conditions). @entity11440 has provided good results and is an alternative for treating @entity1119 at common sites. Our aim was to evaluate the efficacy of @entity11440 as a treatment for primary sweating at uncommon sites (e.g., the back and groin). METHODS: This retrospective study analyzed 20 @entity1 (10 females) who received @entity11440 for primary focal @entity1119 at uncommon sites. The subjects were evaluated to determine quality of life before beginning @entity11440 and six weeks afterward and they were assigned grades (on a scale from 0 to 10) to measure their improvement at each site of excessive sweating after six weeks and at the last consult. RESULTS: The median follow-up time with @entity11440 was 385 days (133-1526 days). The most common sites were the back (n=7) and groin (n=5). After six weeks, the quality of life improved in 85% of the subjects. @entity2133 was very common and was reported by 16 @entity1 , 12 of whom reported moderate/severe @entity2133 . Five @entity1 stopped treatment (two: unbearable @entity2133 , two: excessive @entity2147 and one: palpitations). At the last visit, 80% of @entity1 presented with moderate/great improvement at the main sites of sweating. CONCLUSION: After six weeks, more than 80% of the @entity1 presented with improvements in their overall quality of life and at the most important site of sweating. Side effects were common (80% reported at least one side effect) and caused 25% of the @entity1 to discontinue treatment. @entity11440 is effective for treating bothersome @entity1119 , even at atypical locations and most @entity1 cope well with the side effects.

Treatment of uncommon sites of focal primary XXXX : experience with pharmacological therapy using @entity11440 .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity2133 :: ('MESH:D014987', 'Disease') :: ['dry mouth', 'Dry mouth'] @entity2147 :: ('MESH:D006970', 'Disease') :: ['somnolence'] @entity1119 :: ('MESH:D006945', 'Disease') :: ['hyperhidrosis'] @entity11440 :: ('MESH:C005419', 'Chemical') :: ['Oxybutynin', 'oxybutynin']
@entity1119 :: (MESH:D006945,Disease) :: ['hyperhidrosis']
